Related Experiment Videos
Human osteogenesis involves differentiation-dependent increases in the morphogenically active 3' alternative splicing
D Grisaru1, E Lev-Lehman, M Shapira
1Department of Biological Chemistry, Life Sciences Institute, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Molecular and Cellular Biology
|December 22, 1998
Summary
Osteogenic factors like vitamin D3 enhance E6-AChE mRNA, crucial for bone cell differentiation. Suppressing this mRNA boosts cell proliferation, indicating E6-AChE
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The human acetylcholinesterase (AChE) gene promoter is rich in binding sites for osteogenic factors.
- 1,25-(OH)2 vitamin D3 and 17beta-estradiol are key osteogenic factors influencing gene expression.
Purpose of the Study:
- To investigate the role of E6-AChE mRNA and its encoded isoform in osteogenesis.
- To explore the relationship between E6-AChE expression and the proliferation-differentiation balance in bone cells.
Main Methods:
- Analysis of AChE promoter activity in response to osteogenic factors.
- Use of antisense oligodeoxynucleotides to suppress E6-AChE mRNA expression in Saos-2 cells.
- In vivo studies in fetal chondrocytes, including those with thanatophoric dysplasia.
Main Results:
- Vitamin D3 and 17beta-estradiol enhance E6-AChE mRNA transcription in differentiating osteosarcoma cells.
- Suppression of E6-AChE mRNA leads to increased Saos-2 cell proliferation.
- E6-AChE mRNA levels increase in normally differentiating fetal chondrocytes but not in those with impaired osteogenesis.
Conclusions:
- E6-AChE plays a morphogenic role in regulating the proliferation-differentiation balance during human osteogenesis.
- The findings suggest E6-AChE is a key mediator in normal bone development and differentiation.